Agreement:
I Agree
Body:
Dear Editor
Further to the response by David Phizackerley I can only wonder at the lack of absolute risk [AR] reduction figures and numbers needed to treat [NNT] in this paper. Have we learned nothing? What happened to evidence based medicine and peer review?
No competing Interests:
Yes
The following competing Interests:
Electronic Publication Date:
Saturday, November 18, 2023 – 11:38
Highwire Comment Subject:
Workflow State:
Released
Full Title:
Re: Semaglutide reduces risk of major cardiovascular events by 20%, finds study
Highwire Comment Response to:
Check this box if you would like your letter to appear anonymously::
Last Name:
Price
First name and middle initial:
Simon
Email:
Address:
4 Oakdene Gardens
Occupation:
retired GP
Affiliation:
nil
BMJ: Additional Article Info:
Rapid response